Last Posted: Jun 02, 2018
- PCSK9 genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study
D Lyall et al, BioRxIV preprints, May 31, 2018 - Our Journey and Destination
The FH Foundation, May 2018 - Simplified Canadian Definition for Familial Hypercholesterolemia
I Ruel etb al, CJC, May 2018 - The FH Foundation® Begins Enrollment in PAGENT Study to Improve Understanding of Genetic Testing for Familial Hypercholesterolemia (FH)
S Seim, The FH foundation. May 16, 2018 - Familial Hypercholesterolemia and Pregnancy
G Lundberg et al, Am College Cardiology, May 14, 2018 - Genetic Testing to Assess Risk of Heart Attack
A Cook. Center for Genomic Medicine, May 9, 2018 - The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia.
White C Michael et al. Journal of cardiovascular pharmacology and therapeutics 2018 Jan 1074248418769040 - Cardiovascular Event Reduction with PCSK9 Inhibition Among 1,578 Patients with Familial Hypercholesterolemia: Results from the SPIRE Randomized Trials of Bococizumab
PM Ridker et al, J CLin Lipid, Ape 2018 - Human Genomic Variation- Understanding what makes each of us different and what makes us the same
NHGRI, Apr 6, 2018 - 'I am CardioSmart' Contest Honors Orange County Heart Attack Survivor
Am College Cardiology, Feb 8, 2018
.png)
No hay comentarios:
Publicar un comentario